Company Takeda Pharmaceutical Company Limited London S.E.

Company Takeda Pharmaceutical Company Limited London S.E.

0RN3

JP3463000004

Pharmaceuticals

Analysts' Consensus

Equities

0RN3

JP3463000004

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Takeda Pharmaceutical Company Limited

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Takeda Pharmaceutical Company Limited

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals

Market Closed - London S.E. Other stock markets 04:58:26 26/03/2019 pm IST			5-day change	1st Jan Change
37.59 ^EUR	+6.79%		-.--%	-.--%

25/06	US CDC alerts healthcare providers of increase in dengue cases	RE
25/06	Takeda's Cancer Drug Gets European Commission Approval	MT

Takeda Pharmaceutical Company Limited specializes in the development, manufacturing and marketing of pharmaceutical products especially for metabolic and cardiovascular diseases, cancers and central nervous systems troubles. The activity is organized around 2 areas:

- sale of drugs and consumer care products;

- services.

Net sales are distributed geographically as follows: Japan (17.5%), Asia (5%), the United States (49%), Europe and Canada (20.8%), Latin America (3.8%), Russia and CIS (1.8%) and other (2.1%).

Number of employees: 49,095

JPY in Million	2023	Weight	2024	Weight	Delta
Gastroenterology 28.5 %	1,094,541	27.2 %	1,216,207	28.5 %	+11.12%
Plasma-derivatives Therapies Immunology 19.2 %	678,443	16.8 %	818,570	19.2 %	+20.65%
Neuroscience 14.7 %	637,711	15.8 %	627,014	14.7 %	-1.68%
Rare Genetics and Other 10.9 %	418,724	10.4 %	465,403	10.9 %	+11.15%
Oncology 10.8 %	438,742	10.9 %	462,362	10.8 %	+5.38%
Other 8.7 %	454,598	11.3 %	368,908	8.7 %	-18.85%
Rare Hematology 7.2 %	304,718	7.6 %	305,297	7.2 %	+0.19%

JPY in Million	2023	Weight	2024	Weight	Delta
United States 51.5 %	2,103,772	52.2 %	2,195,711	51.5 %	+4.37%
Europe and Canada 22.7 %	842,668	20.9 %	966,835	22.7 %	+14.73%
Japan 10.6 %	512,043	12.7 %	451,391	10.6 %	-11.85%
Asia 6.1 %	225,007	5.6 %	261,218	6.1 %	+16.09%
Latin America 4.6 %	160,375	4.0 %	198,100	4.6 %	+23.52%
Other 2.8 %	95,182	2.4 %	117,911	2.8 %	+23.88%
Russia / Commonwealth of Independent States 1.7 %	88,431	2.2 %	72,594	1.7 %	-17.91%

Managers	Title	Age	Since
Christophe Weber CEO	Chief Executive Officer	57	01/14/01
Mwana Lugogo CMP	Compliance Officer	54	01/12/01
Michael Mendelsohn CTO	Chief Tech/Sci/R&D Officer	69	01/15/01
Andrew Plump CTO	Chief Tech/Sci/R&D Officer	58	01/15/01
Gabriele Ricci CTO	Chief Tech/Sci/R&D Officer	45	01/22/01
Norimasa Takeda CMP	Compliance Officer	-	-
Haruhiko Hirate IRO	Public Communications Contact	-	-
Takashi Okubo IRO	Public Communications Contact	-	-
Christopher O'Reilly IRC	Investor Relations Contact	-	01/11/01
Marcello Agosti PRN	Corporate Officer/Principal	53	01/19/01

Members of the board	Title	Age	Since
Yoshiaki Fujimori BRD	Director/Board Member	71	01/16/01
Jean-Luc Butel BRD	Director/Board Member	67	01/16/01
Ian Clark BRD	Director/Board Member	62	01/19/01
Steven Gillis BRD	Director/Board Member	71	01/19/01
John Maraganore BRD	Director/Board Member	60	01/22/01
Emiko Higashi BRD	Director/Board Member	64	01/16/01
Masami Iijima CHM	Chairman	73	01/21/01
Koji Hatsukawa BRD	Director/Board Member	72	01/16/01
Christophe Weber CEO	Chief Executive Officer	57	01/14/01
Kimberly Reed BRD	Director/Board Member	53	01/22/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	1,582,418,725	1,568,501,201 ( 99.12 %)	13,405,261 ( 0.8471 %)	99.12 %

Name	Equities	%	Valuation
BlackRock Fund Advisors 3.496 %	55,319,129	3.496 %	1 469 M €
BlackRock Japan Co. Ltd. 2.276 %	36,020,800	2.276 %	957 M €
Nikko Asset Management Co., Ltd. 2.194 %	34,711,100	2.194 %	922 M €
Nippon Life Insurance Co. 1.564 %	24,752,000	1.564 %	657 M €
Takeda Science Foundation 1.132 %	17,912,000	1.132 %	476 M €
TAKEDA PHARMACEUTICAL COMPANY LIMITED 0.4747 %	7,511,300	0.4747 %	199 M €
BlackRock Investment Management (UK) Ltd. 0.3774 %	5,972,275	0.3774 %	159 M €
BlackRock (Netherlands) BV 0.2850 %	4,509,380	0.2850 %	120 M €
Takeda Pharmaceutical Employee Incentive Plan 0.2294 %	3,630,339	0.2294 %	96 M €
IYOGIN HOLDINGS,INC. 0.1818 %	2,876,136	0.1818 %	76 M €

Name	Equities	%	Valuation
Nikko Asset Management Co., Ltd. 2.762 %	87,400,834	2.762 %	1 167 M €
Capital Research & Management Co. (Global Investors) 0.4146 %	13,121,930	0.4146 %	175 M €
Mondrian Investment Partners Ltd. 0.3817 %	12,079,962	0.3817 %	161 M €
Eaton Vance Management 0.1578 %	4,995,623	0.1578 %	67 M €
The Ayco Co. LP 0.1330 %	4,209,431	0.1330 %	56 M €
Renaissance Technologies LLC 0.0985 %	3,118,200	0.0985 %	42 M €
Brandes Investment Partners LP 0.0917 %	2,902,507	0.0917 %	39 M €
Fidelity Management & Research Co. LLC 0.0813 %	2,574,240	0.0813 %	34 M €
Wells Fargo Bank NA 0.0813 %	2,571,467	0.0813 %	34 M €
Millennium Management LLC 0.0734 %	2,322,444	0.0734 %	31 M €

Name	Equities	%	Valuation
BB Gestão de Recursos DTVM SA 0.000068 %	1,076	0.000068 %	14 302 €

Name	Equities	%	Valuation
TAKEDA PHARMACEUTICAL COMPANY LIMITED 0.47%	7,514,200	0.47%	199,540,257 $
HILLEVAX, INC. 13.52%	6,724,000	13.52%	81,629,360 $
DENALI THERAPEUTICS INC. 2.96%	4,214,559	2.96%	78,222,215 $
ASKA PHARMACEUTICAL HOLDINGS CO.,LTD. 7.21%	2,204,000	7.21%	33,085,588 $
OVID THERAPEUTICS INC. 12.38%	8,781,996	12.38%	26,872,908 $
PHATHOM PHARMACEUTICALS, INC. 4.77%	2,790,480	4.77%	26,286,322 $
WAVE LIFE SCIENCES LTD. 0.90%	1,096,892	0.90%	6,778,793 $
NOILE-IMMUNE BIOTECH INC. 18.76%	8,119,800	18.76%	6,768,828 $

Takeda Pharmaceutical Co., Ltd.

4-1-1 Dosho-machi Chuo-Ku

540-8645, Osaka

+81 3 3278 2111

http://www.takeda.co.jp

address Takeda Pharmaceutical Company Limited(0RN3)

Name	Category and Sector
Shire Biotech India Pvt Ltd.
Takeda Austria GmbH Takeda Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Austria GmbH engages in research and development of pharmaceutical products. The company is based in Linz, Austria. Kirsten Detrick has been the CEO of the Austrian company since 2016.	Miscellaneous Commercial Services
Takeda Belgium NV Takeda Belgium NV Medical DistributorsDistribution Services Founded in 1835, Takeda Belgium NV is a subsidiary of Takeda Pharmaceutical Co., Ltd. The company is based in Zaventem, Belgium and focuses on providing better healthcare solutions for their patients. Takeda Belgium's mission is centered around the question of how they can do more for their patients.	Medical Distributors
Takeda Pharmaceuticals U.S.A., Inc. Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL.	Pharmaceuticals: Major
Takeda GmbH Takeda GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Konstanz, Germany. The CEOs are Wolfgang Eck, Uwe Hoffmeister, Roland Kurney. The company was founded in 1873.	Pharmaceuticals: Major
Shire Ireland Finance Trading Ltd.
Shire Biotech UK Holdings Ltd. Shire Biotech UK Holdings Ltd. Financial ConglomeratesFinance Part of Takeda Pharmaceutical Co., Ltd., Shire Biotech UK Holdings Ltd. is an investment holding company. Shire Biotech UK Holdings Ltd. is based in London, UK. Founded in 2017, Shire Biotech UK Holdings functions as an investment holding company.	Financial Conglomerates
Takeda Manufacturing Austria AG Takeda Manufacturing Austria AG Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda Manufacturing Austria AG manufactures and supplies vital medicines and medical devices. The company is based in Vienna, Austria.	Pharmaceuticals: Major
Takeda A/S Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark.	Financial Conglomerates
Takeda Pharmaceuticals International AG Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland.	Pharmaceuticals: Major

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

4,168 JPY

Average target price

4,744 JPY

Spread / Average Target

+13.83%

Consensus

Estimates Revisions

Company calendar

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+54.61%	81TCr
NOVO NORDISK A/S	+44.25%	64TCr
JOHNSON & JOHNSON	-6.33%	35TCr
MERCK & CO., INC.	+20.62%	33TCr
ABBVIE INC.	+10.44%	30TCr
ASTRAZENECA PLC	+18.45%	25TCr
ROCHE HOLDING AG	+2.09%	22TCr
NOVARTIS AG	+13.03%	22TCr
AMGEN INC.	+8.61%	17TCr

Other Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals